En defensa de los programas de reducción de daños para usuarios de drogas inyectables
Authors:
- Julie KulikowskiJKJulie Kulikowski
- Erika LinderELErika Linder
- 1 January 2019
- journal article
- Published by Elsevier in Nursing (Ed. española)
- Vol. 36 (1) , 40-45
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Addressing the Nation’s Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S.American Journal of Preventive Medicine, 2017
- Continuing Links Between Substance Use and HIV Highlight the Importance of Nursing RolesJournal of the Association of Nurses in AIDS Care, 2017
- Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs — United StatesMMWR. Morbidity and Mortality Weekly Report, 2016
- Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjectsAIDS, 2016
- Cost Effectiveness of HIV Prevention Interventions in the U.S.American Journal of Preventive Medicine, 2016
- Reduction in Needle Sharing Among Seattle-Area Injection Drug Users Across 4 Surveys, 1994–2013American Journal of Public Health, 2016
- The cost-effectiveness of harm reductionInternational Journal of Drug Policy, 2015
- Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus InfectionsPLOS ONE, 2014
- Prevention And Treatment Produced Large Decreases In HIV Incidence In A Model Of People Who Inject DrugsHealth Affairs, 2014
- Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectivenessInternational Journal of Drug Policy, 2014